Books > Business & Economics > Economics > Political economy
|
Buy Now
The Politics of Pharmaceutical Policy Reform - A Study of Generic Drug Regulation in Brazil (Paperback)
Loot Price: R1,796
Discovery Miles 17 960
|
|
The Politics of Pharmaceutical Policy Reform - A Study of Generic Drug Regulation in Brazil (Paperback)
Series: SpringerBriefs in Political Science, 26
Expected to ship within 10 - 15 working days
|
Donate to Against Period Poverty
Total price: R1,816
Discovery Miles: 18 160
|
Brazil is renowned worldwide for its remarkable reforms in
pharmaceutical regulation, which have enhanced access to essential
medicines while lowering drug costs. This book innovates by
analysing the generic drug reform in Brazil, demonstrating that
pharmaceutical regulation is only partially influenced by non-state
actors. Little is known about the institutional antecedents and
policy process that channeled this regulatory reform. This is
particularly intriguing because a regulatory shift in the
pharmaceutical sector requires the participation of a number of
stakeholders and interest groups in the policy process. Fonseca
examines the generic drug reform's causes and consequences. No
study has approached the generic drug regulation in Brazil from
this perspective. The Politics of Pharmaceutical Policy Reform: A
Study of Generic Drug Regulation in Brazil, explores the following:
* The politics of pharmaceutical regulation in Brazil over the last
25 years. * The political negotiations to approve the Generic Drug
Act, which involved a hard-to-reach agreement between the
pharmaceutical industry (national and multinational), the Ministry
of Health, and Congress * The controversial decisions to regulate
packaging and pharmaceutical equivalence. * The surprising success
of Brazilian pharmaceutical firms, which became market champions in
a sector largely dominated by multinational firms. * Comparative
lessons from the Brazilian case for the political construction of
regulatory standards to regulate generic drugs and its effects on
global health. This book will interest political scientists and
health policy scholars concerned with the political conflicts in
the pharmaceutical sector. It argues against well-established
approaches to regulatory capture such as control of the regulatory
process by interest groups and policy diffusion. It can be used as
evidence for graduate courses in public policy, health policy and
political science. Because Brazil is one of the largest markets for
pharmaceuticals in the world, business leaders and consultancy
firms would also be interested.
General
Imprint: |
Springer International Publishing AG
|
Country of origin: |
Switzerland |
Series: |
SpringerBriefs in Political Science, 26 |
Release date: |
December 2014 |
First published: |
2015 |
Authors: |
Elize Massard Da Fonseca
|
Dimensions: |
235 x 155 x 7mm (L x W x T) |
Format: |
Paperback
|
Pages: |
117 |
ISBN-13: |
978-3-319-12564-0 |
Categories: |
Books >
Business & Economics >
Economics >
Political economy
|
LSN: |
3-319-12564-8 |
Barcode: |
9783319125640 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.